Meeting to be held in New York on October 5 hosted by Oppenheimer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on FUSN:
- Eli Lilly deal for Point puts radiopharma names in spotlight
- Point Biopharma deal reads positively to radiopharma names, says B. Riley
- Fusion Pharmaceuticals initiated with an Outperform at Oppenheimer
- Fusion Pharmaceuticals price target lowered to $12 from $13 at Raymond James
- Fusion Pharmaceuticals reports Q2 EPS (38c), consensus (39c)